 |
|
Concurrent renal dysfunction with ischemic heart disease is an important determinant for cardiac and cerebrovascular mortality in patients on chronic digoxin therapy for atrial fibrillation
Jong Ho Shin, Ki-Woon Kang, Jae Guk Kim, Soo Joo Lee
Kidney Res Clin Pract. 2018;37(2):130-137. Published online 2018 Jun 30 DOI: https://doi.org/10.23876/j.krcp.2018.37.2.130
|
|
Citations to this article as recorded by
 Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink
Natasha Slater, Simon White, Martin Frisher
Journal of Arrhythmia.2024; 40(1): 47. CrossRef Blood pressure variability and early neurological deterioration according to the chronic kidney disease risk categories in minor ischemic stroke patients
Jae-Chan Ryu, Jae-Han Bae, Sang Hee Ha, Jun Young Chang, Dong-Wha Kang, Sun U. Kwon, Jong S. Kim, Chung Hee Baek, Bum Joon Kim, Donovan Anthony McGrowder
PLOS ONE.2022; 17(9): e0274180. CrossRef Evaluating plasma Digoxin concentration after an intravenous loading dose in patients with renal failure
Eslami Vahid, Mortezapour Fatemeh, Samavat Shiva, Ziae Shadi, Gheymati Azin
Archives of Clinical Nephrology.2021; : 033. CrossRef Cardiorenal syndrome
Myung-Gyu Kim
Journal of the Korean Medical Association.2020; 63(1): 20. CrossRef Low High‐Sensitivity C‐Reactive Protein Level in Korean Patients With Chronic Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW‐CKD
Changhyun Lee, Keun Hyung Park, Young Su Joo, Ki Heon Nam, Tae‐Ik Chang, Ea Wha Kang, Joongyub Lee, Yun Kyu Oh, Ji Yong Jung, Curie Ahn, Kyu‐Beck Lee, Jung Tak Park, Tae‐Hyun Yoo, Shin‐Wook Kang, Seung Hyeok Han
Journal of the American Heart Association.2020;[Epub] CrossRef Association of Gout with Cad and Effect of Antigout Therapy on Cvd Risk among Gout Patients
Wei-Shih Huang, Cheng-Li Lin, Chon-Haw Tsai, Kuang-Hsi Chang
Journal of Investigative Medicine.2020; 68(5): 972. CrossRef Framingham risk score and risk of incident chronic kidney disease: A community-based prospective cohort study
Changhyun Lee, Hae-Ryong Yun, Young Su Joo, Sangmi Lee, Joohwan Kim, Ki Heon Nam, Jong Hyun Jhee, Jung Tak Park, Tae-Hyun Yoo, Shin-Wook Kang, Seung Hyeok Han
Kidney Research and Clinical Practice.2019; 38(1): 49. CrossRef Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry
Ying Gao, Sanshuai Chang, Xin Du, Jianzeng Dong, Xiaoli Xu, Yingchun Zhou, Gregory Y. H. Lip, Changsheng Ma
American Journal of Cardiovascular Drugs.2019; 19(6): 579. CrossRef Impact of Blood or Erythrocyte Membrane Fatty Acids for Disease Risk Prediction: Focusing on Cardiovascular Disease and Chronic Kidney Disease
Oh Yoen Kim, Su Mi Lee, Won Suk An
Nutrients.2018; 10(10): 1454. CrossRef Atrial fibrillation and chronic kidney disease: A bad combination
Márcio Galindo Kiuchi
Kidney Research and Clinical Practice.2018; 37(2): 103. CrossRef
|